Related Experiment Video
Updated: Dec 17, 2025

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor
Amirhossein Mafi1, Soo-Kyung Kim1, William A Goddard2
1Materials and Process Simulation Center (139-74), California Institute of Technology, Pasadena, CA 91125.
Abstract:
Agonists to the μ-opioid G protein-coupled receptor (μOR) can alleviate pain through activation of G protein signaling, but they can also induce β-arrestin activation, leading to such side effects as respiratory depression. Biased ligands to μOR that induce G protein signaling without inducing β-arrestin signaling can alleviate pain while reducing side effects. However, the mechanism for stimulating β-arrestin signaling is not known, making it difficult to design optimum biased ligands. We use extensive molecular dynamics simulations to determine three-dimensional (3D) structures of activated β-arrestin2 stabilized by phosphorylated μOR bound to the morphine and D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO) nonbiased agonists and to the TRV130 biased agonist. For nonbiased agonists, we find that the β-arrestin2 couples to the phosphorylated μOR by forming strong polar interactions with intracellular loop 2 (ICL2) and either the ICL3 or cytoplasmic region of transmembrane (TM6). Strikingly, Gi protein makes identical strong bonds with these same ICLs. Thus, the Gi protein and β-arrestin2 compete for the same binding site even though their recruitment leads to much different outcomes. On the other hand, we find that TRV130 has a greater tendency to bind the extracellular portion of TM2 and TM3, which repositions TM6 in the cytoplasmic region of μOR, hindering β-arrestin2 from making polar anchors to the ICL3 or to the cytosolic end of TM6. This dramatically reduces the affinity between μOR and β-arrestin2.
Insights
Biased opioid ligands offer pain relief with fewer side effects by selectively activating G protein signaling over β-arrestin signaling. This study reveals how biased agonists prevent β-arrestin2 binding to the μ-opioid receptor (μOR), paving the way for safer pain therapeutics.
Area of Science:
- Pharmacology and Molecular Biology
- Computational Chemistry and Biophysics
Background:
- Opioid agonists activate the μ-opioid receptor (μOR) for pain relief via G protein signaling.
- Non-selective activation also recruits β-arrestin, causing side effects like respiratory depression.
- Biased ligands selectively activate G protein signaling, aiming to reduce side effects, but their mechanism is unclear.
Purpose of the Study:
- To elucidate the structural mechanism by which biased ligands interact with the μOR and β-arrestin2.
- To understand why nonbiased agonists and biased agonists induce different signaling outcomes.
Main Methods:
- Extensive molecular dynamics simulations were employed.
- Three-dimensional structures of activated β-arrestin2 stabilized by phosphorylated μOR were determined.
- Interactions with nonbiased agonists (morphine, DAMGO) and a biased agonist (TRV130) were analyzed.
Main Results:
- Nonbiased agonists and Gi protein compete for the same binding site on μOR, interacting with intracellular loops (ICLs) and transmembrane helix 6 (TM6).
- Biased agonist TRV130 binds differently, interacting with extracellular portions of TM2 and TM3.
- TRV130 repositions TM6, sterically hindering β-arrestin2 binding and reducing its affinity to the μOR.
Conclusions:
- The distinct binding modes of biased vs. nonbiased agonists dictate β-arrestin2 recruitment.
- TRV130's interaction with μOR prevents β-arrestin2 anchoring, explaining its biased signaling profile.
- Understanding these structural differences is crucial for designing safer, biased opioid analgesics.
Related Concept Videos
Opioid Receptors: Overview
GPCR Desensitization
Activation and Inactivation of G Proteins
G-Protein Gated Ion Channels
Sensory...
GPCRs Regulate Adenylyl Cylase Activity
G-protein Coupled Receptors

